Avance Biosciences™ is excited to announce that we will be exhibiting at BPI International 2025, taking place September 15–18 at the Hynes Convention Center in Boston, MA. This premier event brings together engineers, scientists, and biotech leaders to explore innovations across the full bioprocessing spectrum, from cell line development and upstream processing to downstream operations and next-generation manufacturing.
At Avance Biosciences, we provide end-to-end analytical, assay development, validation, and testing services designed to support biologics, cell therapies, and gene therapy programs. Our team combines deep expertise in molecular and bioanalytical techniques, including advanced NGS solutions, regulatory-aligned method qualification, ensuring compliance across preclinical, clinical, and commercial stages.
Our new NGS Center of Excellence provides comprehensive sequencing solutions to support biotherapeutic development, including integration site analysis, on/off-target detection, long-read sequencing, and gene editing safety assessments. By combining advanced instrumentation with robust bioinformatics and regulatory-aligned workflows, we help clients generate high-quality, reliable data for clinical, preclinical, and commercial applications – ensuring precision, compliance, and actionable insights throughout the drug development lifecycle.
Visit us at Booth #1508 to meet our team, discuss your program needs, and learn how our analytical solutions can help accelerate your path to market.
We look forward to seeing you in Boston!
See you at BPI International 2025!
When you partner with Avance Biosciences™, you gain a CRO partner that is creative, collaborative and dedicated to sound science with a focus on the regulatory requirements our partners require. Contact our technical staff to discuss how we can support you in your project!
